Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1993; 70(01): 063-067
DOI: 10.1055/s-0038-1646161
DOI: 10.1055/s-0038-1646161
State-of-the-Art Lecture
Hemophilia
Factor VIII Structure and Function
Philip J Fay
Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York, USA
› Author Affiliations
Further Information
Publication History
Publication Date:
03 July 2018 (online)
-
References
- 1 Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor. J Clin Invest 1977; 60: 390-404
- 2 Kaufman RJ, Wasley LC, Dorner AJ. Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem 1988; 263: 6352-6362
- 3 Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. 1990; Blood 76: 1-16
- 4 van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor VIIIa in the activation of bovine factor Xa. J Biol Chem 1981; 256: 3433-3442
- 5 Mutucumarana VP, Duffy EJ, Lollar P, Johnson AE. The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor Villa. J Biol Chem 1992; 267: 17012-17021
- 6 Wood WI, Capon DJ, Simonsen CC, Eaton DL, Gitschier J, Keyt B, Seeburg PH, Smith DH, Hollingshead P, Wion KL. Expression of active human factor VIII from recombinant DNA clones. Nature 1984; 312: 330-337
- 7 Toole JJ, Knopf JL, Wozney JM, Sultzman LA, Beucker JL, Pittman DD, Kaufman RJ, Brown E, Shoemaker C, Orr EC. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 1984; 312: 342-347
- 8 Vehar GA, Keyt B, Eaton D, Rodriguez H, O'Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN. Structure of human factor VIII. Nature 1984; 312: 337-342
- 9 Vehar G, Davie EW. Preparation and properties of bovine factor VIII. Biochemistry 1980; 19: 401-410
- 10 Fass DN, Knutson GJ, Katzmann JA. Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein. Blood 1982; 59: 594-600
- 11 Fulcher CA, Zimmerman TS. Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody. Proc Natl Acad Sci USA 1982; 79: 1648-1652
- 12 Rotblat F, O'Brien DP, O'Brien FJ, Goodall AH, Tuddenham EG. Purification of human factor VIII:C and its characterization by Western blotting using monoclonal antibodies. Biochemistry 1985; 24: 4294-4300
- 13 Andersson LO, Forsman N, Huang K, Larsen K, Lundin A, Pavlu B, Sandberg H, Sewerin K, Smart J. Isolation and characterization of human factor VIII: Molecular forms in commercial factor VIII concentration, cryoprecipitate, and plasma. Proc Natl Acad Sci USA 1986; 83: 2979-2983
- 14 Fay PJ, Anderson MT, Chavin SI, and Marder VJ. The heterodimeric structure of human factor VIII and changes produced by thrombin interaction. Biochim Biophys Acta 1986; 871: 268-278
- 15 Eaton D, Rodriguez H, Vehar G. Proteolytic processing of human factor VIII: Correlation of specific cleavage by thrombin, factor Xa and activation protein C with activity and inactivation of factor VIII coagulant activity. Biochemistry 1986; 25: 505-512
- 16 Hamer RJ, Koedam JA, Beeser-Visser NH, Sixma JJ. Human factor VIII: Purification from commercial factor VIII concentration, characterization, identification and radiolabeling. Biochim Biophys Acta 1986; 873: 356-366
- 17 Fay PJ, Smudzin TM. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor Villa. J Biol Chem 1992; 267: 13246-13250
- 18 Esmon CT. The subunit structure of thrombin activated factor V. J Biol Chem 1979; 254: 964-973
- 19 Fay PJ. Reconstitution of human factor VIII from isolated subunits. Arch Biochem Biophys 1988; 262: 525-531
- 20 Nordfang O, Ezban M. Generation of active coagulation factor VIII from isolated subunits. J Biol Chem 1988; 263: 1115-1118
- 21 Toole JJ, Pittman DD, Orr EC, Murtha P, Wasley LC, Kaufman RJ. A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity. Proc Natl Acad Sci USA, 1986; 83: 5939-5942
- 22 Eaton DL, Wood WI, Eaton D, Hass PE, Hollingshead P, Wion K, Mather J, Lawn RM, Vehar GA, Gorman C. Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule. Biochemistry 1986; 25: 8343-8347
- 23 Mosesson MW, Fass DN, Lollar P, DiOrio JP, Parker CG, Knutson GJ, Hainfeld JF, Wall JS. Structural model of porcine factor VIII and factor VIIIa molecules based on scanning transmission electron microscope (STEM) images and STEM mass analysis. J Clin Invest 1990; 85: 1983-1990
- 24 Fowler WE, Fay PJ, Arvan D, and Marder VJ. Electron microscopy of human factor V and factor VIII: Correlation of morphology with domain structure and localization of factor V activation fragments. Proc Natl Acad Sci USA 1990; 87: 7648-7652
- 25 Fay PJ, Smudzin TM. Inter-subunit fluorescence energy transfer in human factor VIII. J Biol Chem 1989; 264: 14005-14010
- 26 Owen WG, Wagner RH. Anti-hemophilic factor: Separation of an active fragment following dissociation by salts or detergents. Thromb Diath Haemorrh 1982; 27: 502-515
- 27 Lollar P, Parker CG. Stoichiometry of the porcine factor VIII-von Willebrand factor association. J Biol Chem 1987; 262: 17572-17576
- 28 Andersson LO, Brown JE. Interaction of factor VIII-von Willebrand factor with phospholipid vesicles. Biochem J 1981; 100: 161-167
- 29 Nesheim M, Pittman DD, Giles AR, Fass DN, Wang JH, Slonosky D, Kaufman RJ. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. J Biol Chem 1991; 166: 17815-17820
- 30 Hamer RJ, Koedam JA, Beeser-Visser NH, Bertina RM, vanMourik JA, Sixma JJ. Factor VIII binds to von Willebrand factor via its Mr~80,000 light chain. Eur J Biochem 1987; 166: 37-43
- 31 Bloom JW. The interaction of rDNA factor VIII, factor VIIIdes797-1562 and factor VIIIdeS797-1562-derived peptides with phospholipid. Thromb Res 48: 439-448 1987;
- 32 Foster PA, Fulcher CA, Houghten RA, Zimmerman TS. An immunogenic region with residues Val1670-Glu1684 of factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor. J Biol Chem 1988; 263: 5230-5234
- 33 Leyte A, van Schijndel HB, Niehrs C, Huttner WB, Verbeet MP, Mertens K, vanMourik JA. Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J Biol Chem 1990; 266: 740-746
- 34 Foster PA, Fulcher CA, Houghten RA, Zimmerman TS. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phos-phatidylserine. Blood 1990; 75: 1999-2004
- 35 Leyte A, Verbeet MP, Brodniewicz-Probe T, vanMourik JA, Mertens K. The interaction between human blood coagulation factor VIII and von Willebrand factor: Characterization of a high affinity binding site on factor VIII. Biochem J 1989; 157: 679-683
- 36 Gilbert GE, Furie BC, Furie B. Binding of human factor VIII to phospholipid vesicles. J Biol Chem 1990; 265: 815-822
- 37 Lollar P, Knutson GJ, Fass DN. Activation of porcine factor VIII:C by thrombin and factor Xa. Biochemistry 1985; 24: 6056-6064
- 38 Pieters J, Lindhout T, Hemker HC. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma. Blood 1989; 74: 1021-1024
- 39 Koedam JA, Hamer RJ, Besser-Visser NH, Bouma BN, Sixma JJ. The effect of von Willebrand factor on activation of factor VIII by factor Xa. Eur J Biochem 1990; 1898: 229-234
- 40 Bihoreau N, Sauger A, Yon JM, van de Pol H. Isolation and characterization of different activated forms of factor VIII. Eur J Biochem 1989; 185: 111-118
- 41 Hill-Eubanks DC, Parker CG, Lollar P. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin. Proc Natl Acad Sci USA 1989; 86: 6508-6512
- 42 Hill-Eubanks DC, Lollar P. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain. J Biol Chem 1990; 265: 17854-17858
- 43 Pittman DD, Kaufman RJ. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII). Proc Natl Acad Sci USA 1988; 85: 2429-2433
- 44 Lollar P, Parker CG. Subunit structure of thrombin-activated porcine factor VIII. Biochemistry 1989; 28: 666-674
- 45 Fay PJ, Haidaris PJ, Smudzin TM. Human factor VIIIa subunit structure: Reconstitution of factor Villa from the isolated A1/A3-C1-C2 dimer and A2 subunit. J Biol Chem 1991; 266: 8957-8962
- 46 Lollar P, Parker CG. pH-dependent denaturation of thrombin-activated porcine factor VIII. J Biol Chem 1990; 265: 1688-1692
- 47 Lamphear BJ, Fay PJ. Factor IXa enhances reconstitution of factor VIIIa from isolated A2 subunit and A1/A3-C1-C2 dimer. J Biol Chem 1992; 267: 3725-3730
- 48 Hultin MB, Jesty J. Activation and inactivation of human factor VIII by thrombin: Effects of inhibitors of thrombin. Blood 1981; 57: 476-482
- 49 Rick ME, Hoyer LW. Thrombin activation of factor VIII: Effects of inhibitors. Br J Haematol 1977; 36: 585-597
- 50 Lollar P, Parker ET, Fay PJ. Coagulant properties of hybrid human/porcine factor VIII molecules. J Biol Chem 1992; 267: 23652-23657
- 51 Duffy EJ, Parker ET, Mutucumarana VP, Johnson AE, Lollar P. Binding of factor VIIa and factor VIII to factor IXa on phospholipid vesicles. J Biol Chem 1992; 267: 17006-17011
- 52 Lollar P, Knutson GJ, Fass DN. Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid. Blood 1984; 63: 1303-1308
- 53 Lollar P, Fass DN. Inhibition of activated porcine factor IX by dan-syl-glutamyl-glycyl-arginyl-chloromethylketone. Arch Biochem Bio-phys 1984; 233: 438-446
- 54 O'Brien DP, Johnson D, Byfield P, Tuddenham EG. Inactivation of factor VIII by factor IXa. Biochemistry 1992; 31: 2805-1812
- 55 Lamphear BJ, Fay PJ. Proteolytic interactions of factor IXa with human factor VIII and factor VIIa. Blood 1992; 80: 3120-3126
- 56 Walker FJ, Fay PJ. Regulation of blood cogulation by the protein C system. FASEB J 1992; 6: 2562-2567
- 57 Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS. Proteolytic inactivation of human factor VIII procoagulant protein by activated protein C and its analogy with factor V. Blood 1984; 63: 486-489
- 58 Walker FJ, Chavin SI, Fay PJ. Inactivation of factor VIII by activated protein C and protein S. Arch Biochem Biophys 1987; 252: 322-328
- 59 Fay PJ, Smudzin TM, Walker FJ. Activated protein C catalyzed inactivation of human factor VIII and factor VIIIa: Identification of cleavage sites and correlation of proteolysis with cofactor activity. J Biol Chem 1991; 266: 20139-20145
- 60 Odegaard B, Mann KG. Proteolysis of factor Va by factor Xa and activated protein C. J Biol Chem 1987; 262: 11233-11238
- 61 Guinto ER, Esmon CT. Loss of prothrombin and factor Xa-factor Va interaction upon inactivation of factor Va by activated protein C. J Biol Chem 1984; 259: 13986-13992
- 62 Aly AM, Higuchi M, Kasper CK, Kazazian HH, Antonarakis SE, Hoyer LW. Hemophilia A due to mutations that create new N-glyco-sylation sites. Proc Natl Acad Sci USA 1992; 89: 4933-4937
- 63 Suzuki K, Stenflo J, Dahlback B, Theodorsson B. Inactivation of human coagulation factor V by activated protein C. J Biol Chem 1983; 258: 1914-1920
- 64 Fay PJ, Walker FJ. Inactivation of human factor VIII by activated protein C: Evidence that the factor VIII light chain contains the activated protein C binding site. Biochim Biophys Acta 1989; 994: 142-148
- 65 Krishnaswamy S, Williams EB, Mann KG. The binding of activated protein C to factor V and Va. J Biol Chem 1986; 261: 9684-9693
- 66 Walker FJ, Scandella D, Fay PJ. Identification of the binding site for activated protein C on the light chain of factor V and factor VIII. J Biol Chem 1990; 265: 1484-1489
- 67 Koedam JA, Meijers JCM, Sixma JJ, Bouma B. Inactivation of factor VIII by activated protein C: Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 1988; 82: 1236-1243
- 68 Fay PJ, Coumans JV, Walker FJ. von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. J Biol Chem 1991; 266: 2172-2177
- 69 Walker JF, Sexton PW, Esmon CT. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochim Biophys Acta 1979; 571: 333-342
- 70 Nesheim ME, Canfield WM, Kisiel W, Mann KG. Studies of the capacity of factor X to protect factor Va from inactivation by activated protein C. J Biol Chem 1982; 257: 1443-1447
- 71 Solymoss S, Tucker MM, Tracy PB. Kinetics of inactivation of membrane-bound factor Va by activated protein C. J Biol Chem 1988; 263: 14884-14890
- 72 Bertina RM, Cupers R, van Wijngaardon A. Factor IXa protects activated factor VIII against inactivation by activated protein C. Biochem Biophys Res Commun 1984; 125: 177-183
- 73 Rick ME, Esmon NL, Krizek DM. Factor IXa and von Willebrand factor modify the inactivation of factor VIII by activated protein C. J Lab Clin Med 1990; 115: 415-421